A detailed history of Engineers Gate Manager LP transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 109,994 shares of XERS stock, worth $797,456. This represents 0.01% of its overall portfolio holdings.

Number of Shares
109,994
Previous 38,040 189.15%
Holding current value
$797,456
Previous $177,000 402.82%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$4.68 - $8.3 $336,744 - $597,218
71,954 Added 189.15%
109,994 $890,000
Q2 2025

Aug 14, 2025

BUY
$3.95 - $5.16 $150,258 - $196,286
38,040 New
38,040 $177,000

Others Institutions Holding XERS

About Xeris Biopharma Holdings, Inc.


  • Ticker XERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,956,992
  • Market Cap $986M
  • Description
  • Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...
More about XERS
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.